-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
International war "epidemic" operation
Add new members to the "Arsenal" of Covid-19! American scientists wrote in the "Nature" magazine published on the 21st that their experiments on mice and hamsters showed that the combination therapy composed of two antibodies "strongly work together" is effective against a variety of (but not all) new coronavirus mutations.
Antibody therapy is usually used to treat inpatients and critically ill patients with the new crown, but with the emergence of mutated new strains one after another, whether antibody therapy is effective against the new strains has become an urgent question to be answered
In the latest study, scientists at the University of Washington School of Medicine tested on mice and hamsters infected with a mutant strain of the new coronavirus, which have been approved by the U.
The tested variant strains include the Alpha strain first found in the UK, the first beta strain found in South Africa, the first Gamma strain found in Brazil, and new variants similar to the Delta variant strain first found in India.
The researchers evaluated these antibodies and antibody combinations in mice and hamsters
The results of the study show that the anti-coronavirus drugs made of two antibodies, even if one of the antibodies has lost part or all of the ability to neutralize the mutant strain, the combined antibody (even if the dose is relatively low) can maintain the treatment of the mutant strain.
The lead author of the research paper, Dr.
